• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$3.33 -$0.10 (-2.92%)

REAL-TIME: Last trade at

Orexigen Therapeutics, Inc.

NASDAQ:OREX

Jump to this page for:

Related Resources

3 Health-Care Stocks Crushing the Market

5/26/2012 by DailyFinance

Investing in Weight Loss Ahead of This Summer’s FDA Decisions

5/23/2012 by Trefis

NASDAQ Changes Up Biotech Index Members & Weightings

5/14/2012 by 247wallst

Why This Biotech Crushed the Market

5/14/2012 by DailyFinance

Will the Dow Hold On?

5/11/2012 by DailyFinance

Diet Pill Maker Arena Pharmaceuticals Wins Backing of FDA Advisers

5/11/2012 by Minyanville

Let the Obesity-Drug Wars Begin

5/11/2012 by DailyFinance

24/7 Wall St. Closing Bell

5/11/2012 by 247wallst

Whoa! 2 Stocks That Bucked the Dow

5/10/2012 by DailyFinance

The Dow Busts Its Slump

5/10/2012 by DailyFinance

Diet Pill Maker Arena Pharmaceuticals' Stock Jumps Ahead of US Review

5/8/2012 by Minyanville

Contrarian Ideas: Stocks on Losing Streaks With Bullish Investor Trends

4/24/2012 by DailyFinance

Arena Shares Sink as Big Dates for Diet Pill Makers Near

4/17/2012 by Minyanville

Zacks' Voice of the People highlights opportunities with Starbucks, Realty Income, Keryx Biopharma,

4/12/2012 by Nasdaq

Latest RTMB Trades - Voice of the People

4/11/2012 by Nasdaq

VIVUS Faces Shareholder Risks After FDA Delay On Obesity Pill (VVUS, ARNA, OREX)

4/10/2012 by 247wallst

Investors Pile Into Arena

4/4/2012 by DailyFinance

Buy, Sell, or Hold: Arena Pharmaceuticals

3/31/2012 by DailyFinance

Another Big Setback for Obesity Drug Makers?

3/30/2012 by DailyFinance

Will Obesity Drugs Do Better in Europe?

3/29/2012 by DailyFinance

Arena Pharma Drug under EU Review - Analyst Blog

3/27/2012 by Nasdaq

FDA Talks Heart Trials for Obesity Drugs

3/27/2012 by DailyFinance

Arena Files for European Drug Review (ARNA, VVUS, OREX)

3/26/2012 by 247wallst

Stocks Shaking the Investment World

3/12/2012 by DailyFinance

Hefty Profits in Store for Obesity-Drug Makers

2/29/2012 by DailyFinance

Time to Go Overweight on Obesity-Drug Makers?

2/27/2012 by DailyFinance

Yeah, I'd Call That a Confident Recommendation

2/23/2012 by DailyFinance

1 Reason VIVUS is an Instant Double

2/22/2012 by DailyFinance

No Way? Obesity Drugs Have Side Effects

2/17/2012 by DailyFinance

Diet Pill Scorecard: Vivus, Arena, Orexigen Still Chasing Market Approvals

1/13/2012 by Minyanville

Has Arena Pharmaceuticals Become the Perfect Stock?

1/11/2012 by DailyFinance

Don't Believe This Company's Warning

1/9/2012 by DailyFinance

Arena Pharma Files Response to CRL - Analyst Blog

1/6/2012 by Nasdaq

This Biotech's Obese To-Do List Is Done

1/4/2012 by DailyFinance

Working Through the Obese To-Do List in 2011

12/30/2011 by DailyFinance

VIVUS' Obese Pink Elephant

12/22/2011 by DailyFinance

US Stock Futures: HOT STOCKS TO WATCH

12/15/2011 by Smart Money

US Stock Futures: HOT STOCKS TO WATCH

12/15/2011 by Smart Money

Zacks #1 Rank Additions for Thursday - Tale of the Tape

12/8/2011 by Nasdaq

Even With a Pill That Works Faster Than Viagra, Vivus Isn't a Buy

11/14/2011 by Minyanville
See More Articles...